U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06811350) titled 'Quality Improvement Initiative for Enhancing Early Mobilization in Intracerebral Hemorrhage Patients' on Jan. 13.
Brief Summary: Primary intracerebral hemorrhage (ICH) is a severe and life-threatening condition with a high mortality rate, reaching up to 50% within the first month. Survivors are often at risk of long-term disability due to the extensive brain damage caused by the hemorrhage. Unlike ischemic stroke patients, ICH patients are typically younger, face longer hospital stays, and are more likely to experience acute complications. Modern treatment approaches have shifted from focusing solely on reducing mortality to minimizi...